Advertisement
Canada markets close in 5 hours 51 minutes

  • S&P/TSX

    21,673.32
    -200.40 (-0.92%)
     

  • S&P 500

    4,997.56
    -74.07 (-1.46%)
     

  • DOW

    37,782.76
    -678.16 (-1.76%)
     

  • CAD/USD

    0.7288
    -0.0010 (-0.14%)
     

  • CRUDE OIL

    82.42
    -0.39 (-0.47%)
     

  • Bitcoin CAD

    87,161.53
    -3,639.90 (-4.01%)
     

  • CMC Crypto 200

    1,371.65
    -10.92 (-0.79%)
     

  • GOLD FUTURES

    2,331.50
    -6.90 (-0.30%)
     

  • RUSSELL 2000

    1,961.27
    -34.16 (-1.71%)
     

  • 10-Yr Bond

    4.7270
    +0.0750 (+1.61%)
     

  • NASDAQ

    15,426.46
    -286.29 (-1.82%)
     

  • VOLATILITY

    17.30
    +1.33 (+8.33%)
     

  • FTSE

    8,045.72
    +5.34 (+0.07%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6810
    -0.0009 (-0.13%)
     
MARKETS LIVE BLOG:

STOCKS SLIDE AFTER META'S REALITY CHECK, WITH GDP ON DECK

Owner of Facebook and Instagram plans to spend up to US$10B on AI infrastructure investments

Global Anti-obesity Drugs Market Forecast 2020-2030

ReportLinker
·4 min read

Mechanism of Action, Innovator Drugs, Generics. Prescription Drugs, OTC, Duration of Therapy, Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA Receptor Agonists, Sympathomimetics, Short-term Drugs, Long-term Drugs.

New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Anti-obesity Drugs Market Forecast 2020-2030" - https://www.reportlinker.com/p04763516/?utm_source=GNW

The global anti-obesity drugs market is estimated to have reached $1.9bn in 2019 and is expected to grow at a CAGR of 32% in the first half of the forecast period. In 2019, the innovator drugs submarket held 75% of the global anti-obesity drugs market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 285-page report you will receive 146 tables and 137 figures– all unavailable elsewhere.

The 285-page report provides clear detailed insight into the anti-obesity drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

? Global Anti-obesity Drugs Market forecast from 2020-2030

? Global Anti-obesity Drugs Market analysis and forecast from 2018-2028, by Mechanism of Action:
? Incretion mimetics/GLP-1 agonists
? SNDRIs
? Lipase Inhibitors
? Serotonin receptor agonists
? Sympathomimetic-GABA receptor agonists
? Sympathomimetics

? Global Anti-obesity Drugs Market analysis and forecast from 2020-2030, by Duration of Therapy:
? Long-term Drugs
? Short-term Drugs

? Global Anti-obesity Drugs Market analysis and forecast from 2020-2030, by Innovator vs Generic Drugs:
? Innovator
? Generic Drugs

? Global Anti-obesity Drugs Market analysis and forecast from 2020-2030, by Prescription vs OTC:
? Prescription Drugs
? OTC

? This report discusses and provides revenue forecasts from 2020-2030 for selected anti-obesity drugs:
? Saxenda
? Contrave/Mysimba
? Belviq
? Qysmia
? Xenical
? Alli

? This report provides individual revenue forecasts from 2020-2030 for these regional and national markets:
? US
? Japan
? EU5: Germany, France, Spain, Italy, UK
? BRIC: Brazil, Russia, China, India
? RoW

Each national market is further segmented by submarket: mechanism of action, duration of therapy, prescription vs OTC, innovator vs generic drugs.

? Our study discusses the selected leading companies that are the major players in the anti-obesity drugs market:
? Arena Pharmaceuticals
? AstraZeneca
? Carmot Therapeutics
? CohBar
? Currax Pharmaceuticals LLC
? Eisai
? ERX Pharmaceuticals
? Gelesis
? GlaxoSmithKline (GSK)
? Hanmi Pharmaceutical
? LNC Therapeutics
? Novartis
? Novo Nordisk
? Pfizer
? Rhythm Pharmaceuticals, Inc.
? Roche
? Saniona
? Scohia Pharma, Inc.
? Sinil Pharmaceutical Co., Ltd
? Takeda
? Teva
? Vivus

? This report discusses novel mechanism of action, active pipeline molecules and promising pipeline molecules.

? This report gives an overview of pricing and reimbursement in the US and EU.

? This report provides a SWOT Analysis of the global anti-obesity drugs market.

? Key questions answered by this report:

? How is the anti-obesity drugs market evolving?
? What is driving and restraining anti-obesity drugs dynamics?
? How will each anti-obesity drugs submarket market grow over the forecast period and how much Sales will these submarkets account for in 2030?
? How will market shares of each anti-obesity drugs submarket develop from 2020-2030? Which individual technologies will prevail and how will these shifts be responded to?
? Which anti-obesity drugs submarket will be the main driver of the overall market from 2020-2030?
? How will political and regulatory factors influence regional anti-obesity drugs markets and submarkets?
? Will leading national anti-obesity drugs markets broadly follow macroeconomic dynamics, or will individual country sectors outperform the rest of the economy?
? How will market shares of the national markets change by 2030 and which nation will lead the market in 2030?
? Who are the leading players and what are their prospects over the forecast period?
? How will the sector evolve as alliances form during the period between 2020 and 2030?

This study is intended for anyone requiring commercial analyses for the anti-obesity drugs market. You find data, trends and predictions.
Read the full report: https://www.reportlinker.com/p04763516/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001